SynthesisFrontiers in oncology2022

Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis.

Jiaqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.